Seagen Investor Relations Material
Latest events
Q4 2022
Seagen
Q3 2023
1 Nov, 2023
Q2 2023
2 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seagen Inc
Access all reports
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer. The company markets LONZA (vinorelbine tartrate) injection, which is used to treat various types of cancer. It also focuses on the development of Seaglass (poly-L-glutamic acid), a compound that is undergoing clinical study for the treatment of chemotherapy-induced nausea and vomiting (CINV). The company was formerly known as Ocean Pharmaceuticals, Inc. and changed its name to Seagen Inc. in August 1995. Seagen Inc. is based in Bothell, Washington.
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
SGEN
Country
🇺🇸 United States